Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094679 · ClinicalTrials.gov registry record · Phase 3
Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia
A Phase 3 study of Amblyopia, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 189
- Enrollment target
- 1
- Study location
NCT00094679 is a Phase 3 study of Amblyopia that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 189 participants, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00094679, a Phase 3 study of Amblyopia, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 189 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with minimal patching (2 hours) for moderate amblyopia. * To develop more precise estimates than currently available for the visual acuity improvement that occurs during treatment of amblyopia with patching. * To identify factors that may be associated with successful treatment of amblyopia with patching.
Conditions Studied
Interventions
- DEVICE Eye patch
Study Locations (1)
Maryland
- Wilmer Eye Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2001-05 |
| Est. Completion | 2002-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00094679
The ClinicalTrials.gov registry entry for NCT00094679 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (20% higher). The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Eye patch is the first listed.
NCT00094679 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00094679 about?
NCT00094679 is a clinical study titled "Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia". The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with minimal patching (2 hours) for moderate amblyopia. * To develop more precise estimates than currently available f...
What is the current status of trial NCT00094679?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 189 participants. The study started on 2001-05. Estimated completion is 2002-09.
What conditions does trial NCT00094679 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT00094679?
The interventions under investigation include: Eye patch (DEVICE).
Who is sponsoring clinical trial NCT00094679?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00094679 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
-
Amblyopia (Lazy Eye) Treatment Study
COMPLETED · Phase 3
-
Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children
COMPLETED · Phase 3
-
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.